CA3017931C - Nanocapsules de principe actif liposoluble, fabrication et utilisations - Google Patents

Nanocapsules de principe actif liposoluble, fabrication et utilisations Download PDF

Info

Publication number
CA3017931C
CA3017931C CA3017931A CA3017931A CA3017931C CA 3017931 C CA3017931 C CA 3017931C CA 3017931 A CA3017931 A CA 3017931A CA 3017931 A CA3017931 A CA 3017931A CA 3017931 C CA3017931 C CA 3017931C
Authority
CA
Canada
Prior art keywords
nanocapsules
colloidal suspension
ionic surfactant
suspension according
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3017931A
Other languages
English (en)
French (fr)
Other versions
CA3017931A1 (fr
Inventor
Damien PREVERAUD
Veronique Rosilio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
Adisseo France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adisseo France SAS filed Critical Adisseo France SAS
Publication of CA3017931A1 publication Critical patent/CA3017931A1/fr
Application granted granted Critical
Publication of CA3017931C publication Critical patent/CA3017931C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Colloid Chemistry (AREA)
  • Fodder In General (AREA)
  • General Preparation And Processing Of Foods (AREA)
CA3017931A 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations Active CA3017931C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1652592 2016-03-25
FR16/52592 2016-03-25
PCT/FR2017/050622 WO2017162963A1 (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Publications (2)

Publication Number Publication Date
CA3017931A1 CA3017931A1 (fr) 2017-09-28
CA3017931C true CA3017931C (fr) 2024-01-09

Family

ID=56263861

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3017931A Active CA3017931C (fr) 2016-03-25 2017-03-17 Nanocapsules de principe actif liposoluble, fabrication et utilisations

Country Status (14)

Country Link
US (1) US10765639B2 (enExample)
EP (1) EP3432729B1 (enExample)
JP (1) JP2019513359A (enExample)
KR (1) KR20180128025A (enExample)
CN (1) CN108882729A (enExample)
AU (1) AU2017236312B2 (enExample)
BR (1) BR112018069392B1 (enExample)
CA (1) CA3017931C (enExample)
ES (1) ES3040905T3 (enExample)
MX (1) MX2018011620A (enExample)
RU (1) RU2745844C2 (enExample)
UA (1) UA127243C2 (enExample)
WO (1) WO2017162963A1 (enExample)
ZA (1) ZA201806197B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102370217B1 (ko) * 2019-11-27 2022-03-07 군산대학교 산학협력단 유자 오일을 포함하는 나노복합체의 제조방법
RU2736051C1 (ru) * 2020-03-04 2020-11-11 Александр Александрович Кролевец Способ получения нанокапсул сухого экстракта эхинацеи
RU2743010C1 (ru) * 2020-03-23 2021-02-12 Таисия Скандарбековна Гутнова Способ получения нанокапсул витамина D3
CN114847488A (zh) * 2022-05-17 2022-08-05 江南大学 一种高稳定性和生物可给率的橘味维生素a-维生素d纳米复合载体制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788007B1 (fr) * 1999-01-05 2001-02-09 Oreal Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
FR2803203B1 (fr) 1999-12-31 2002-05-10 Fournier Ind & Sante Nouvelles formulations galeniques du fenofibrate
FR2806005B1 (fr) * 2000-03-10 2002-06-14 Univ Claude Bernard Lyon Procede de preparation de particules colloidales sous forme de nanocapsules
FR2814380B1 (fr) * 2000-09-25 2002-11-08 Serobiologiques Lab Sa Poudre de microcapsules et procede d'obtention
JP2005028559A (ja) * 2003-07-08 2005-02-03 Shinobu Ito ナノカプセル
FR2864900B1 (fr) * 2004-01-09 2007-10-12 Oreal Dispersion aqueuse de nanocapsules a coeur huileux
US8877217B2 (en) * 2005-10-18 2014-11-04 Amorepacific Corporation Cationic polymer nanoparticles encapsulating an active ingredients, and the cosmetic composition containing the same
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
FR2924943A1 (fr) * 2007-12-18 2009-06-19 Galderma Sa Composition dermatologique comprenant des nanocapsules polymeriques de calcitriol, son procede de preparation et son utilisation
BRPI0805854A2 (pt) * 2008-10-10 2010-08-24 Biolab Sanus Farmaceutica Ltda sistema nanoparticulado, processo de preparaÇço do mesmo, uso do mesmo, composiÇço fotoproterora, processo de preparaÇço da mesma, mÉtodo de prevenÇço de doenÇas e distérbios da pele
NZ595984A (en) * 2009-04-24 2014-04-30 Iceutica Pty Ltd Production of encapsulated nanoparticles at commercial scale
EP2266546A1 (en) * 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
ES2351756B1 (es) * 2009-07-28 2011-10-05 Universidad Del Pais Vasco Nanopartículas lipídicas para terapia génica.
US20150231069A1 (en) * 2014-02-20 2015-08-20 Pankaj Modi Oral formulations of chemotherapeutic agents
RU2557900C1 (ru) * 2014-03-25 2015-07-27 Александр Александрович Кролевец Способ получения нанокапсул витаминов
US10391060B2 (en) * 2015-08-06 2019-08-27 Rubicon Research Private Limited Particulate delivery systems

Also Published As

Publication number Publication date
CA3017931A1 (fr) 2017-09-28
RU2745844C2 (ru) 2021-04-01
JP2019513359A (ja) 2019-05-30
US10765639B2 (en) 2020-09-08
RU2018135575A (ru) 2020-04-27
BR112018069392B1 (pt) 2022-11-22
MX2018011620A (es) 2019-03-14
AU2017236312A1 (en) 2018-10-18
ES3040905T3 (en) 2025-11-05
RU2018135575A3 (enExample) 2020-06-09
ZA201806197B (en) 2019-06-26
US20190083414A1 (en) 2019-03-21
CN108882729A (zh) 2018-11-23
EP3432729B1 (fr) 2025-08-13
EP3432729A1 (fr) 2019-01-30
BR112018069392A2 (pt) 2019-01-22
UA127243C2 (uk) 2023-06-21
AU2017236312B2 (en) 2021-02-04
WO2017162963A1 (fr) 2017-09-28
KR20180128025A (ko) 2018-11-30

Similar Documents

Publication Publication Date Title
Wang et al. Influence of soy lecithin concentration on the physical properties of whey protein isolate-stabilized emulsion and microcapsule formation
AU2008340061B2 (en) Microcapsules comprising a fat -soluble active substance
CA3017931C (fr) Nanocapsules de principe actif liposoluble, fabrication et utilisations
US20170326077A1 (en) Homogenous composition and methods of making the same
BR112017002301B1 (pt) Composição compreendendo gotículas hidrofóbicas, método de preparação de uma composição, e, produto consumível
MC2034A1 (fr) Preparations
Gómez-Guillén et al. Bioactive and technological functionality of a lipid extract from shrimp (L. vannamei) cephalothorax
WO2015022454A1 (fr) Nouveau systeme solide instantane auto-emulsionnant a base de cyclodextrines et d'huile (s) pour l'administration orale
JPH10510563A (ja) 抗酸化組成物
JP4934840B2 (ja) 脂溶性ビタミンないし脂溶性ビタミン様物質の油脂−糖質粉末素材及びその製造方法
JP7184633B2 (ja) レチノール内包リポソーム
EP2752202B1 (en) Soft capsule pharmaceutical preparation, composition for soft capsule pharmaceutical preparation, and method for producing soft capsule pharmaceutical preparation
Pascual-Silva et al. Storage stability and antioxidant properties of vegetable and marine lecithin liposomes loaded with sea cucumber (Holothuria forskali) and musky octopus (Eledone moschata) protein hydrolysates
Kalladathvalappil Venugopalan et al. Enhancement of oxidative stability of polyunsaturated fatty acid-rich fish oil: microencapsulation using chitosan-whey protein complex and betalain
Pylypenko et al. Nanobiotechnological obtaining of liposomal forms of antioxidant preparations based on bioflavonoids
EP4161285A1 (fr) Formulation de vitamine a
JP2011240221A (ja) 脂溶性機能性化合物エマルション及びその製造方法
FR2745979A1 (fr) Additif alimentaire pour animaux
Fatima et al. Comparative Analysis of Bio Accessibility of Various Bioactive Compounds Encapsulated in Nanoemulsions: In-Vitro Git Model Study
TW201325620A (zh) 卵磷脂載體囊泡及製備其之方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210

EEER Examination request

Effective date: 20220210